Light instead of injections: A new drug delivery system that automatically releases medication from an in vivo medical device by simply shining light whenever the drug injection is needed.
A new concept of on-demand drug delivery system has emerged in which the drugs are automatically released from in vivo medical devices simply by shining light on the skin.
A research team led by Professor Sei Kwang Hahn of the Department of Materials Science and Engineering and Professor Kilwon Cho of the Department of Chemical Engineering at POSTECH have together developed an on-demand drug delivery system (DDS) using an organic photovoltaic cell coated with upconversion nanoparticles. This newly developed DDS allows nanoparticles to convert skin-penetrating near-infrared (NIR) light into visible light so that drug release can be controlled in medical devices installed in the body. These research findings were published in Nano Energy on March 1, 2021.
For patients who need periodic drug injections as in the case of diabetes, DDSs that automatically administer drugs in lieu of repetitive shots are being researched and developed. However, its size and shape have been restricted due to limitations in power supply for operating such a device.
The research team found the answer in solar power. Upconversion nanoparticles were used for the photovoltaic device to induce photovoltaic power generation with NIR light that can penetrate the skin. An organic photovoltaic cell coated with a core-shell structured upconversion nanoparticles was designed to operate a drug delivery system made of a mechanical and electronic system by generating an electric current upon irradiation of NIR light. When electricity is applied in this manner, the thin gold film sealing the drug reservoir melts and the drug is released.
“The combination of a flexible photovoltaic cell and a drug delivery system enables on-demand drug release using light,” explained Professor Sei Kwang Hahn. “The drug delivery system is activated using near-infrared light that is harmless to the human body and is highly skin-penetrating.”
He added, “Since this enables nimble control of drug release of medical devices inserted into the body by using near-infrared light, it is highly anticipated to contribute to the development of phototherapy technology using implantable medical devices.”
Original Article: POSTECH joint research team develops near-infrared (NIR) light triggered drug delivery system
More from: Pohang University of Science and Technology
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Near-infrared light triggered drug delivery
- Researchers hit ‘milestone’ in light therapy for spinal cord injury study
Published in the journal Bioengineering and Translational Medicine, the team’s research indicates there is an optimal ‘dose’ for the therapeutic approach, and that it can realise therapeutic ...
- Nanotechnology in Therapeutics
Nanomedicine. 2012;7(8):1253-1271. Although passive targeting approaches form the basis of clinical therapy, they suffer from several limitations. Ubiquitously targeting cells within a tumor is ...
- Red light therapy for repairing spinal cord injury passes milestone
Patients with spinal cord injury (SCI) could benefit from a future treatment to repair nerve connections using red and near-infrared ... of light required to achieve maximum restoration of function ...
- News tagged with infrared light
The IRIS infrared beamline at the BESSY II storage ring now offers a fourth option for characterizing materials, cells and even molecules on different length scales. The team has extended the IRIS ...
- Drug Delivery News and Research
University of North Carolina at Chapel Hill researchers have developed a new drug delivery platform that harnesses helical amyloid fibers designed to untwist and release drugs in response to body ...
Go deeper with Google Headlines on:
Near-infrared light triggered drug delivery
[google_news title=”” keyword=”near-infrared light triggered drug delivery” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
On-demand drug delivery
- Embedding Sustainability in Drug Delivery through Industry Consensus at CPHI NA
At CPHI NA, Rachel Harris, AstraZeneca, spoke on her work at BioPhorum to enable industry consensus and action for sustainability with drug delivery devices.
- The Worsening Prescription Drug Shortage and How to Cope With It
The number of prescription drugs in shortage climbed to a 10-year high of 323 in the first quarter of 2024 – including some crucial hard-to-substitute drugs.
- Transdermal Drug Delivery Systems Market Strategies: How to Stay Competitive in 2024-2032
Global Transdermal Drug Delivery Systems Market is valued approximately at USD 59.16 billion in 2022 and is anticipated to grow with a growth rate of more than 11.90% over the forecast period ...
- Ocular Drug Delivery Market Updates 2024 : Rise in…
According to a new report published by Allied Market Research, titled, “Ocular Drug Delivery Market,” The ocular drug delivery market size was valued at $67.7 billion in 2022, and is estimated to ...
- Injectable drug delivery market poised for 8.6% CAGR growth until 2029
Revenue for the global injectable drug delivery market is set to grow by $1139.4b at a compound ... Moreover, the ageing global population has driven up the demand for injectable medications for ...
Go deeper with Google Headlines on:
On-demand drug delivery
[google_news title=”” keyword=”on-demand drug delivery” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
[embedyt] https://www.youtube.com/embed?listType=playlist&list=PL0UjJ07OSXC83oV409r1yRju8-ihA1InJ&layout=gallery[/embedyt]